dr. marfu'ah binti nik eezamuddeen

pegawai perubatan ud53

jab radioterapi & onkologi, hukm

 marfuah@ppukm.ukm.edu.my



   Biografi/ Biography :

  • PEGAWAI PERUBATAN UD53

  • teh sx, norlia a, nordashima as, elia shazniza s, marfuah ne, shahizon azura mm.  (2024).  mammary angiosarcoma in an adolescent : a case report.  - medicine & health.  315-323. 

     

    nik nuratiqah nik abeed, boon hau ng, hilawati yusof, marfu'ah nik ezzamudden, andrea yu lin ban, mohamed faisal abdul hamid.  (2023).  massive lung metastasis secondary to germ cell testicular tumor.  - respirology.  327. 

     

    hardip singh gendeh; ramesh kumar; fuad ismail; marfuah nik eexamuddeen; shahizon azura mohamed mukari; siti khadijah hamsan..  (2023).  sterotactic surgery for multiple brain lesions: a paradigm shift.  - malaysian journal of medicine case reports.  172-175. 

     

    siti nur akmal ghazali, caryn mei hsien chan, marfuah nik eezamuddeen, hanani abdul manan dan noorazrul yahya.  (2023).  quality of life for head and neck cancer patients: a 10 year bibliographic analysis.  - cancers.  1-13. 

     

    ramesh kumar, beehong soon, fuad ismail, marfuah nik ezzamudden, shahizon azura mohamed mukari, aida widure mustapha mohd mustapha, aida hani mohd kalok, norlia abdullah, ian paddick, siti khadijah hamsan.  (2023).  gamma knife radiosurgery: a safe and effective treatment for brain metastases in pregnancy.  - the 8th meeting of the asian leksell gamma knife society.  135--. 

     

    nik nuratiqah nik abeed, boon hau ng, hilawati yusof, marfu'ah nik ezzamudden, andrea yu lin ban, mohamed faisal abdul hamid.  (2023).  massive lung metastasis secondary to germ cell testicular tumor.  - respirology.  327. 

     

    siti nur akmal ghazali, caryn mei hsien chan, marfuah nik eezamuddeen, hanani abdul manan dan noorazrul yahya.  (2023).  quality of life for head and neck cancer patients: a 10 year bibliographic analysis.  - cancers.  1-13. 

     

    nik nuratiqah nik abeed, boon hau ng, hilawati yusof, marfu'ah nik ezzamudden, andrea yu lin ban, mohamed faisal abdul hamid.  (2023).  massive lung metastasis secondary to germ cell testicular tumor.  - respirology.  327. 

     

    siti nur akmal ghazali, caryn mei hsien chan, marfuah nik eezamuddeen, hanani abdul manan dan noorazrul yahya.  (2023).  quality of life for head and neck cancer patients: a 10 year bibliographic analysis.  - cancers.  1-13. 

     

    ramesh kumar, beehong soon, fuad ismail, marfuah nik ezzamudden, shahizon azura mohamed mukari, aida widure mustapha mohd mustapha, aida hani mohd kalok, norlia abdullah, ian paddick, siti khadijah hamsan.  (2023).  gamma knife radiosurgery: a safe and effective treatment for brain metastases in pregnancy.  - the 8th meeting of the asian leksell gamma knife society.  135--. 

     

    nur syafiqah abd hakim, azyani yahya, marfuah nik eezamuddeen, nurul aina fatiha jamli, puteri hanis nafisah megat kamilazmi,nadiah abu.  (2023).  clinical validation of a circanapc7 basescope probe for the detection of folfox chemoresistant colorectal cancer via in situ hybridization.  - 9th regional conference on molecular medicine (rcmm) in conjunction with 5th national conference for cancer research (nccr).  1. 

     
    Geran / Grant Kolaborator / Collaborator Status
    A RANDOMIZED, OPEN-LABEL, PHASE 3 STUDY OF COSIBELIMAB (CK-301) IN COMBINATION WITH PLATINUM+PEMETREXED CHEMOTHERAPY IN SUBJECTS WITH FIRST-LINE METASTATIC NON-SQUAMOUS NON-SMALL CELL LUNG CANCER [PROTOCOL NO. CK-301-301] checkpoint therapeutics, inc.
    78% (2021-06-10 sehingga 2025-06-09)
    A RANDOMIZED, DOUBLE-BLIND STUDY EVALUATING PHARMACOKINETIC SIMILARITY OF ABP 206 COMPARED WITH OPDIVO® (NIVOLUMAB) IN RESECTED STAGE III OR STAGE IV MELANOMA SUBJECTS IN THE ADJUVANT SETTING parexel international (malaysia) sdn bhd
    50.2% (2023-06-22 sehingga 2025-08-21)
    PHASE 1 STUDY INVESTIGATING THE SAFETY, TOLERABILITY, PHARMACOKINETICS, AND PRELIMINARY ANTITUMOR ACTIVITY OF THE ANTI‑OX40 AGONIST MONOCLONAL ANTIBODY BGB-A445 IN COMBINATION WITH THE ANTI-PD-1 MONOCLONAL ANTIBODY TISLELIZUMAB IN PATIENTS WITH ADVANCED S beigene singapore pte. ltd
    56.7% (2022-11-10 sehingga 2025-11-09)
    A GLOBAL, PHASE 3, RANDOMIZED, MULTICENTER, OPEN-LABEL STUDY TO INVESTIGATE THE EFFICACY AND SAFETY OF FURMONERTINIB COMPARED TO PLATINUM-BASED CHEMOTHERAPY AS FIRST-LINETREATMENT FOR PATIENTS WITH LOCALLY ADVANCED OR METASTATIC NON-SMALL CELL LUNG CANCE arrivent biopharma, inc
    17% (2023-07-27 sehingga 2029-05-26)
    A RANDOMIZED, DOUBLE-BLIND STUDY EVALUATING THE EFFICACY, SAFETY, AND IMMUNOGENICITY OF ABP 206 COMPARED WITH OPDIVO® (NIVOLUMAB) IN SUBJECTS WITH TREATMENT-NAïVE UNRESECTABLE OR METASTATIC MELANOMA parexel international (malaysia) sdn bhd
    31.5% (2024-01-04 sehingga 2025-10-03)